Davis Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Davis Capital Management's MRK Position: Q3 2026 in Review
Davis Capital Management increased its Merck (MRK) stake by 121% in Q3 2026, buying an estimated $9.7K and bringing the position to 128 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #220.
Davis Capital Management first reported a position in MRK in Q1 2020 and has held it in 13 quarters since. The position peaked at $330K in Q1 2024. 3,373 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Davis Capital Management held 128 shares of Merck worth $18.6K as of Q3 2026.
- Davis Capital Management bought 70 Merck shares in Q3 2026, an estimated $9.7K.
- Merck made up 0.01% of Davis Capital Management's portfolio in Q3 2026, its #220 holding.
- Davis Capital Management first reported a position in Merck in Q1 2020 and has held it in 13 quarters since.
- Davis Capital Management's Merck position peaked at $330K in Q1 2024.
- 3,373 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.